293 related articles for article (PubMed ID: 28593513)
1. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
Brunetti-Pierri N; Ng P
Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
[TBL] [Abstract][Full Text] [Related]
2. [Advances in helper-dependent adenoviral vector--a review review].
Fu Y; He J; Shi C; Hong T
Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):147-52. PubMed ID: 19445167
[TBL] [Abstract][Full Text] [Related]
3. Helper-dependent adenoviral vectors for liver-directed gene therapy.
Brunetti-Pierri N; Ng P
Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
[TBL] [Abstract][Full Text] [Related]
4. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
5. Helper-Dependent Adenoviral Vectors and Their Use for Neuroscience Applications.
Montesinos MS; Satterfield R; Young SM
Methods Mol Biol; 2016; 1474():73-90. PubMed ID: 27515075
[TBL] [Abstract][Full Text] [Related]
6. [In vitro transgenic expression efficacy of a helper-dependent adenoviral vector encoding enhanced green fluorescent protein].
Zheng X; He J; Fu Y; Xu S; Xie C; Shi C; Zhang M; Wang X; Hong T
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1108-15. PubMed ID: 21090116
[TBL] [Abstract][Full Text] [Related]
7. Helper-dependent adenoviral vectors in experimental gene therapy.
Józkowicz A; Dulak J
Acta Biochim Pol; 2005; 52(3):589-99. PubMed ID: 16082408
[TBL] [Abstract][Full Text] [Related]
8. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
[TBL] [Abstract][Full Text] [Related]
9. Methods for the production of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Methods Mol Biol; 2008; 433():33-53. PubMed ID: 18679616
[TBL] [Abstract][Full Text] [Related]
10. Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors.
Brunetti-Pierri N; Ng T; Iannitti D; Cioffi W; Stapleton G; Law M; Breinholt J; Palmer D; Grove N; Rice K; Bauer C; Finegold M; Beaudet A; Mullins C; Ng P
Hum Gene Ther; 2013 Aug; 24(8):761-5. PubMed ID: 23902403
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons.
Dindot S; Piccolo P; Grove N; Palmer D; Brunetti-Pierri N
Hum Gene Ther; 2011 Jun; 22(6):745-51. PubMed ID: 21175294
[TBL] [Abstract][Full Text] [Related]
12. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
Seiler MP; Cerullo V; Lee B
Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
[TBL] [Abstract][Full Text] [Related]
13. Helper-dependent adenoviral vectors for gene therapy.
Palmer DJ; Ng P
Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
[TBL] [Abstract][Full Text] [Related]
14. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
15. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.
Vetrini F; Ng P
Curr Pharm Des; 2011; 17(24):2488-99. PubMed ID: 21774769
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of helper-dependent adenoviral vectors for sustained in vivo gene therapy.
Oka K; Chan L
Methods Mol Med; 2005; 108():329-50. PubMed ID: 16028693
[TBL] [Abstract][Full Text] [Related]
17. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system.
Zou L; Zhou H; Pastore L; Yang K
Mol Ther; 2000 Aug; 2(2):105-13. PubMed ID: 10947937
[TBL] [Abstract][Full Text] [Related]
18. Helper-dependent adenoviral vector achieves prolonged, stable expression of interleukin-10 in rabbit carotid arteries but does not limit early atherogenesis.
Du L; Dronadula N; Tanaka S; Dichek DA
Hum Gene Ther; 2011 Aug; 22(8):959-68. PubMed ID: 21198399
[TBL] [Abstract][Full Text] [Related]
19. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
[TBL] [Abstract][Full Text] [Related]
20. Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression.
Ross PJ; Kennedy MA; Parks RJ
J Virol; 2009 Sep; 83(17):8409-17. PubMed ID: 19515759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
